James Investment Research Inc Guardant Health, Inc. Transaction History

James Investment Research Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	SELL	$98.77 - $132.17 $37,532 - $50,224	-380 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$109.77 - $165.68 $41,712 - $62,958	380 New	380 $47,000
Q1 2021 Apr 22, 2021	SELL	$127.04 - $179.1 $164,135 - $231,397	-1,292 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$99.96 - $135.93 $129,148 - $175,621	1,292 New	1,292 $167,000
Q2 2020 Jul 24, 2020	SELL	$60.49 - $97.5 $115,838 - $186,712	-1,915 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$59.49 - $82.78 $113,923 - $158,523	1,915 New	1,915 $150,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.